Endogenous retroviruses drive KRAB zinc-finger protein family expression for tumor suppression.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
10 2020
Historique:
received: 17 04 2020
accepted: 04 09 2020
entrez: 22 10 2020
pubmed: 23 10 2020
medline: 14 4 2022
Statut: epublish

Résumé

Gene expression aberration is a hallmark of cancers, but the mechanisms underlying such aberrations remain unclear. Human endogenous retroviruses (HERVs) are genomic repetitive elements that potentially function as enhancers. Since numerous HERVs are epigenetically activated in tumors, their activation could cause global gene expression aberrations in tumors. Here, we show that HERV activation in tumors leads to the up-regulation of hundreds of transcriptional suppressors, namely, Krüppel-associated box domain-containing zinc-finger family proteins (KZFPs). KZFP genes are preferentially encoded nearby the activated HERVs in tumors and transcriptionally regulated by these adjacent HERVs. Increased HERV and KZFP expression in tumors was associated with better disease conditions. Increased KZFP expression in cancer cells altered the expression of genes related to the cell cycle and cell-matrix adhesion and suppressed cellular growth, migration, and invasion abilities. Our data suggest that HERV activation in tumors drives the synchronized elevation of KZFP expression, presumably leading to tumor suppression.

Identifiants

pubmed: 33087347
pii: 6/43/eabc3020
doi: 10.1126/sciadv.abc3020
pmc: PMC7577720
pii:
doi:

Substances chimiques

Zinc J41CSQ7QDS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Cancer Res. 2017 Oct 15;77(20):5445-5451
pubmed: 28807941
J Clin Invest. 2018 Nov 1;128(11):4804-4820
pubmed: 30137025
Science. 2016 Mar 4;351(6277):1083-7
pubmed: 26941318
Nat Genet. 2019 Apr;51(4):611-617
pubmed: 30926969
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Database (Oxford). 2017 Jan 1;2017:
pubmed: 28605766
Genome Res. 2006 May;16(5):669-77
pubmed: 16606702
Nat Rev Genet. 2019 Jul;20(7):417-431
pubmed: 30867571
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):12992-7
pubmed: 20615953
Nat Rev Cancer. 2006 May;6(5):369-81
pubmed: 16633365
Cell. 2018 Apr 5;173(2):386-399.e12
pubmed: 29625054
Mol Biol Evol. 2012 Jan;29(1):239-47
pubmed: 21813467
Nat Genet. 2019 Sep;51(9):1380-1388
pubmed: 31427791
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cell. 2015 Jan 15;160(1-2):48-61
pubmed: 25594174
Nat Commun. 2018 Dec 21;9(1):5416
pubmed: 30575746
Nat Protoc. 2007;2(2):329-33
pubmed: 17406593
Nucleic Acids Res. 2018 Jul 2;46(W1):W242-W245
pubmed: 29762716
Nat Rev Genet. 2007 Apr;8(4):272-85
pubmed: 17363976
Cell. 2018 Apr 5;173(2):283-285
pubmed: 29625045
JCI Insight. 2018 Aug 23;3(16):
pubmed: 30135306
Nucleic Acids Res. 2013 Jan;41(Database issue):D110-7
pubmed: 23161672
Proc Natl Acad Sci U S A. 2016 May 10;113(19):5364-9
pubmed: 27078102
Development. 2017 Aug 1;144(15):2719-2729
pubmed: 28765213
Mol Cancer Ther. 2009 Aug;8(8):2103-9
pubmed: 19671746
Cell Stem Cell. 2019 May 2;24(5):724-735.e5
pubmed: 31006620
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Nat Rev Genet. 2017 Feb;18(2):71-86
pubmed: 27867194
Mob DNA. 2016 Dec 1;7:24
pubmed: 27980689
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Cell. 2017 Feb 9;168(4):629-643
pubmed: 28187285
PLoS One. 2010 Dec 08;5(12):e15082
pubmed: 21170338
Science. 2018 Oct 26;362(6413):
pubmed: 30361341
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Genome Res. 2014 Dec;24(12):1963-76
pubmed: 25319995
Nature. 2014 Dec 18;516(7531):405-9
pubmed: 25317556
Int J Biochem Cell Biol. 2012 Mar;44(3):469-74
pubmed: 22226817
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
PLoS Genet. 2017 Jul 12;13(7):e1006883
pubmed: 28700586
Cancer Metastasis Rev. 2009 Jun;28(1-2):5-14
pubmed: 19153674
Cell Rep. 2018 Apr 10;23(2):512-521
pubmed: 29642008
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Nature. 2001 Feb 15;409(6822):860-921
pubmed: 11237011
Nat Genet. 2010 Jul;42(7):631-4
pubmed: 20526341
Genome Res. 2019 Oct;29(10):1578-1590
pubmed: 31537638
Mol Cancer Ther. 2010 Feb;9(2):268-78
pubmed: 20124450
Nature. 2017 Mar 23;543(7646):550-554
pubmed: 28273063
Cell. 2004 Jan 23;116(2):235-46
pubmed: 14744434
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278

Auteurs

Jumpei Ito (J)

Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 1088639, Japan.

Izumi Kimura (I)

Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 1088639, Japan.

Andrew Soper (A)

Laboratory of Systems Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 6068507, Japan.

Alexandre Coudray (A)

School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.

Yoshio Koyanagi (Y)

Laboratory of Systems Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 6068507, Japan.

Hirofumi Nakaoka (H)

Division of Human Genetics, National Institute of Genetics, Mishima 4118540, Japan.

Ituro Inoue (I)

Division of Human Genetics, National Institute of Genetics, Mishima 4118540, Japan.

Priscilla Turelli (P)

School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.

Didier Trono (D)

School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.

Kei Sato (K)

Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 1088639, Japan. ksato@ims.u-tokyo.ac.jp.
CREST, Japan Science and Technology Agency, Kawaguchi, Saitama 3320012, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH